Skip to content

Effect of Unani formulation in Diabetes mellitus

Effect of Qurs-e-Ziabetus as adjuvant in the management of Type-2 Diabetes Mellitus: A randomized controlled study - DM

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/02/031099
Enrollment
40
Registered
2021-02-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Qurs-e-Ziabetus: Powder of Qurs-e-Ziabetus formulation 7gm filled in capsules will be given in two divided doses. Control Intervention1: Placebo: 7gm wheat flour filled in capsules will

Sponsors

National Institute of Unani Medicine
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of Type-2 Diabetes mellitus taking Gender : Both genders Fasting blood sugar (FBS) >= 126 mg/dl- Postprandial blood sugar (PPBS) >=140 mg/dl- HbA1c >= 6.5% - For metabolic control: BMI 20-35Kg/m2 Waist circumference male>=90 cm, female >=80 cm Triglycerides HDL Blood Pressure SBP >= 130 mmHg, or DBP >= 85 mmHg

Exclusion criteria

Exclusion criteria: Fasting blood sugar (FBS) >250mg/dl Postprandial blood sugar (PPBS) >350mg/dl HbA1c 10% Triglycerides > 499 mg/dl HDL >70 mg/dl Aged 70 years Known cases of Type-2 Diabetes Mellitus with complications. Pregnant & lactating Women. History of any acute diseases or systemic illnesses. History of any other disorders of metabolism. Patients who are on medication > 2 antihyperglycemic drugs changes in the type or dose of antihyperglycemic drugs treatment, History of smoking, and alcohol abuse.

Design outcomes

Primary

MeasureTime frame
1.FBS, PPBS 2.HbA1c Timepoint: every 2 weeks (2nd, 4th, 6th, and 8th weeks) for 8 weeks

Secondary

MeasureTime frame
1.Metabolic control â?¢BMI (body mass index) â?¢Waist circumference â?¢Lipid profile: Triglyceride (TG), and Total cholesterol (TC), High density lipoprotein(HDL), Low density lipoprotein(LDL) â?¢Blood pressure (systolic/diastolic) in mmHg 2.Improvement in Asian DQOL (for Quality of Life)Timepoint: every 2 weeks (2nd, 4th, 6th, and 8th weeks) for 8 weeks

Countries

India

Contacts

Public ContactAMJAD SAIFI

National Institute of Unani Medicine

dr.mobeen@rediffmail.com8123143721

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026